2013 Annual Meeting | Controversies in Neuroscience Plenary Session
| 04:00 PM - 04:30 PM |
Should Intra-arterial Therapy be Used as Standard Treatment of Acute Stroke?
Pooja Khatri, MD, FAAN, Raul G. Nogueira, MD |
|
| 04:30 PM - 05:00 PM |
Should Levodopa Be Initiated at the Time of Diagnosis?
C. W. Olanow, MD, Stephen G. Reich, MD, FAAN |
|
| 05:00 PM - 05:30 PM |
Do Currently Applied Stem Cell Treatments Have Any Validity in the Treatment of Neurologic Disorders?
Lawrence Goldstein, PhD, Arnold R. Kriegstein, MD, PhD |
|
| 05:30 PM - 06:00 PM |
Is the Evidence Sufficient to Give Vitamin D to Everybody in the General Population to Prevent Multiple Sclerosis?
Alberto Ascherio, MD, PhD, George C. Ebers, MD |
| George C. Ebers, MD | No disclosure on file |
| Arnold R. Kriegstein, MD, PhD | No disclosure on file |
| C. W. Olanow, MD | Dr. Olanow has received personal compensation for serving as an employee of Clintrex Research Corporation. Dr. Olanow has received personal compensation in the range of $1,000,000+ for serving as an officer or member of the Board of Directors for Clintrex Research Corporation. Dr. Olanow has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for Chevron/Syngenta. Dr. Olanow has stock in Clintrex Research Corporation. |
| Stephen G. Reich, MD, FAAN | Dr. Reich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Best Doctors. Dr. Reich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UpToDate. Dr. Reich has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various law firms. The institution of Dr. Reich has received research support from ninds. Dr. Reich has received publishing royalties from a publication relating to health care. Dr. Reich has received publishing royalties from a publication relating to health care. |
| Pooja Khatri, MD, FAAN | The institution of Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lumosa. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bayer. The institution of Dr. Khatri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Diamedica. Dr. Khatri has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Basking Biosciences. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association. The institution of Dr. Khatri has received research support from Cerenovus. Dr. Khatri has received publishing royalties from a publication relating to health care. |
| Raul G. Nogueira, MD | Dr. Nogueira has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for for advisory roles with Anaconda, Biogen, Cerenovus, Genentech, Hybernia, Imperative Care, Medtronic, Phenox, Philips, Prolong Pharmaceuticals, Stryker Neurovascular, Shanghai Wallaby, and Synchron (consulting fees) as well as for advisory roles with Astrocyte, Brainomix, Cerebrotech, Ceretrieve, Corindus Vascular Robotics, Vesalio, Viz-AI, RapidPulse and Perfuze ( stock options). Dr. Nogueira has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Law Firms. Dr. Nogueira has received stock or an ownership interest from Viz-AI, Perfuze, Cerebrotech, Reist/Q'Apel Medical, Truvic, and Viseon. The institution of Dr. Nogueira has received research support from Cerenovus. |
| Alberto Ascherio, MD, PhD | The institution of Dr. Ascherio has received research support from NIH and US Department of Defense . |
| Lawrence Goldstein, PhD | No disclosure on file |